Substance / Medication

Relebactam

Overview

Active Ingredient
relebactam
RxNorm CUI
2184137

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

8 trials linked to this intervention

8
Total Trials
1
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy and safety of imipenem/cilastatin/relebactam (IMI/CS/REL): a meta-analysis of randomized controlled clinical trials.
Lei Wenjuan, Duan Yan, Xin Mingyan et al. · BMC Infect Dis · 2025
PMID: 41013394Meta-AnalysisFull text (PMC)
Thorough QTc Study of a Single Supratherapeutic Dose of Relebactam in Healthy Participants.
Boundy Keith, Liu Yang, Bhagunde Pratik et al. · Clin Pharmacol Drug Dev · 2020
PMID: 32212418RCT
Restoring Control: Real-World Success with Imipenem-Relebactam in Critical MDR Infections-A Multicenter Observational Study.
Marino Andrea, Pipitone Giuseppe, Venanzi Rullo Emmanuele et al. · Pathogens · 2025
PMID: 40732731ObservationalFull text (PMC)
Effectiveness of imipenem-relebactam for multidrug-resistantin pneumonia and bloodstream infections in the United States (MIRAGE).
Wangchinda Walaiporn, Wu Janet Y, Abbo Lilian M et al. · Antimicrob Agents Chemother · 2025
PMID: 41201892ObservationalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Relebactam (substance)
SNOMED CT
789066008
UMLS CUI
C4317244
RxNorm CUI
2184137

Clinical Data

This intervention maps to 3 entities in the Healos knowledge graph.

3
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
8
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.